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Abstract
Recent advancement in the area of green fluorescent protein techniques coupled with microscopic imaging has
significantly contributed in defining and dissecting subcellular changes of apoptosis with high spatio-temporal resolution.
Although single cell based studies using EGFP and associated techniques have provided valuable information of initiation
and hierarchical changes of apoptosis, they are yet to be exploited for multiparameter cell based real time analysis for
possible drug screening or pathway defining in a high throughput manner. Here we have developed multiple cancer cell
lines expressing FRET sensors for active caspases and adapted them for high throughput live cell ratio imaging, enabling
high content image based multiparameter analysis. Sensitivity of the system to detect live cell caspase activation was
substantiated by confocal acceptor bleaching as well as wide field FRET imaging. Multiple caspase-specific activities of
DEVDase, IETDase and LEHDase were analysed simultaneously with other decisive events of cell death. Through
simultaneous analysis of caspase activation by FRET ratio change coupled with detection of mitochondrial membrane
potential loss or superoxide generation, we identified several antitumor agents that induced caspase activation with or
without membrane potential loss or superoxide generation. Also, cells that escaped the initial drug-induced caspase
activation could be easily followed up for defining long term fate. Employing such a revisit imaging strategy of the same
area, we have tracked the caspase surviving fractions with multiple drugs and its subsequent response to retreatment,
revealing drug-dependent diverging fate of surviving cells. This thereby indicates towards a complex control of drug
induced tumor resistance. The technique described here has wider application in both screening of compound libraries as
well as in defining apoptotic pathways by linking multiple signaling to identify non-classical apoptosis inducing agents, the
greatest advantage being that the high content information obtained are from individual cells rather than being population
based.
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Introduction
Since the identification of the first caspase in the early 1990s
and later when better biological systems for apoptosis study were
described, the field of cell death research has taken a giant surge.
Today, this has led to the identification of molecular mechanisms
of newer forms of physiological cell death other than apoptosis like
paraptosis, autophagy, necrosis and necroptosis that cross-regulate
each other and have common molecular intermediates in deciding
and executing the ultimate cell fate [1–6]. Mitochondrial outer
membrane permeabilization (MOMP), intermembrane space
(IMS) protein release, activation of pro-apoptotic Bcl-2 and
caspase family proteins have been identified as key events in the
initiation, progression and execution of apoptosis [7–12]. But,
there is still much that we do not understand about how cell death
signaling is fine-regulated particularly, how the signaling within a
single cell is coordinated for its ultimate orchestration at the
population level. For example, there is no clarity about why cell-
to-cell variability in death execution exists and whether the
hierarchical and spatiotemporal events are integrated at the
cellular level or at the population level [13–15]. This is because the
techniques of study used thus far have been limited to either single
cell studies or population level studies only.
Recent single cell studies using time-lapse confocal microscopy
of green fluorescent protein (GFP) tagged apoptotic intermediates
like cytochrome C and FRET probes for caspase activation have
given valuable insights into the initiation and progression of the
hierarchical events of apoptosis signaling within single cells
[16,17], thereby throwing light into the subcellular changes and
spatio-temporal relationship between two events. Further, single
cell studies have contributed in understanding the ‘point-of-no-
return’ or the nature of two different cells that respond differently
[18,19]. Given the advantages, single cell studies are still not
sufficient in giving an integrated picture of the subcellular events
and the effect of these in a single cell on the population as a whole.
This is because, in spite of the fact that single cell studies give real
time low-noise information in single cells, concomitant analysis of
the response of the whole population is practically impossible using
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based studies inspite of giving robust results, bear noise as well as
fail to give details of subcellular spatial and temporal apoptotic
events as in single cell studies.
Basic cancer research has given us remarkable insights into our
understanding of the biology of cancer with the realization that
apoptosis and the genes that control it have a profound effect on
the malignant phenotype [20,21]. Cancer-generating mutations
disrupt apoptosis, leading to tumor initiation, progression or
metastasis. The mutations that suppress apoptosis also reduce the
sensitivity to cancer treatment [22]. Considering the enormous
evidence linking cancer and apoptosis, it appears that screens of
apoptosis rather than the cell protein content status are far more
superior for anticancer drug screening [23,24]. However,
miniaturization of apoptosis detection screens for highthroughput
assays remains a challenge. Caspase activation is an accepted read-
out of apoptosis and proteinase activity and can be exploited for
biomolecular screening [25]. Caspase activation can be detected
by measurement of catalytic activity, immunoblotting, immuno-
labeling using conformation-sensitive antibodies or affinity labeling
followed by flow cytometry. Out of these, live cell real time
detection of activity is possible only by a FRET based probe-
cleavage study [26,27]. All the other methods either require cell-
free protein extracts to be prepared or cell fixation done, thus
being non-adaptable for a live cell high throughput (HTS) study.
Current caspase activation HTS assays are based on fluorigenic
substrates or FRET based probes, the former being an end-point
detection. Also, the FRET based live cell HTS detection systems
developed so far have failed to give quantitative information in a
cell-to-cell specific, real-time manner, or are not adaptable for
multiparameter analysis [28].
We have developed a novel highthroughput platform in cell
lines of varying origins that could be adopted for real time,
multiparameter apoptosis detection and high content drug
screening. To enable simultaneous detection and analysis of
multiple parameters using spectrally similar fluorophores, spatially
separated segmentation masks were employed. By employing this
approach, we have identified novel non-conventional apoptosis
induction mechanisms of certain drugs. A high content screening
platform to assay multiple death signals like caspase activation,
MMP loss, chromatin condensation and mitochondrial superoxide
generation simultaneously in live cells as is shown in our study
helps to link the interrelationship of these critical events in the
execution of cell death in HTS fashion. Through a time kinetics
study we found two response groups of ‘sudden’ acting and
‘gradual’ acting drugs. This assay is useful for comparing caspase
activation profiles among different cell lines as well as for that of
initiator and effector caspase activity in the same cell line itself.
Another important advantage of the platform described is long
term fate analysis of non-responsive cells. Using this, we report a
non-caspase 9 mediated pathway of death induction of 3 classes of
compounds in the cell population that survived initial death
induction by these same compounds. This is the first ever report of
a highthroughput platform which records subcellular signals from
individual cells so as to give a more accurate picture of the whole
population and thus becomes useful in the real-time tracking of
multiple apoptosis parameters in live cells, that can be adapted for
direct screening of drugs for multiple cellular signaling.
Materials and Methods
Cell culture and drug addition
All cells were maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM, Gibco) containing 10% Fetal Bovine Serum
(FBS) and antibiotics in a humidified CO2 (5%) chamber at 37uC.
For experiments, cells were seeded in 96 well plates at desired
densities. After an overnight culture, medium was removed and
100 ml fresh phenol-red free DMEM containing 5% FBS with the
compounds to be tested were added. Concentrated stocks of each
drug was prepared in either DMSO or water according to
solubility and stored at 280uC. The list of drugs used, known
mechanism of action and the respective concentration have been
given in supplemental information (Table S1).
Expression vectors and generation of stable cell lines
SCAT3 and SCAT9 vectors were kindly gifted by Dr. Masayuki
Miura, University of Tokyo, Japan [30]. The former is linked with
preferred caspase 3/7-specific DEVD recognition site and the
latter with caspase 9-specific recognition site LEHD in between
donor and acceptor. SCAT 8 was supplied by Dr. Markus Rehm,
Royal College of Surgeons in Ireland, Ireland that is intercon-
nected with short linker of preferred caspase-8/-10 recognition site
IETD between donor and acceptor [16]. Cell transfection was
performed using Lipofectamine
TM 2000 (Invitrogen, Carlsbad,
CA) as per the manufacturer’s instructions. Stably expressing
clones were generated by selecting the cells in 800 mg/ml of G418
(Invitrogen, Carlsbad, CA) containing medium for 30–45 days.
Following clonal propagation, the multiple clones with different
levels of transgene expression were expanded and further sorted
based on quantitative FRET, analysed by FACS Aria (Becton
Dickinson) so as to obtain an enriched population of SCAT3,
SCAT8 and SCAT9 expressing cells with optimum default FRET.
Briefly, cells were excited with 407 nm laser and the FRET-high
cells were identified from the scatter plot of ECFP emission
collected using 450640 nm filter against EYFP emission collected
using 530630 nm filter.
FRET acceptor bleaching by Confocal laser scanning
microscopy
Cells seeded in chambered coverglass (Lab-Tek
TM, Nunc,
Rochester, NY) were sequentially scanned using a laser scanning
Leica TCS SP2 Confocal microscope (Leica Microsystems,
Germany) for donor (ECFP) and acceptor (Venus) fluorescence
signals under the 458 nm and 514 nm laser lines respectively to
obtain pre-bleach donor intensity (Donorpre) and pre-bleach
images. Following this, the acceptor was bleached off completely
with high intensity 514 nm laser pulses after which, the donor
intensity was obtained (Donorpost) and FRET efficiency was
calculated using the formula: % FRET efficiency=(Donorpost2
Donorpre)/Donorpost. Pre-bleach and post-bleach donor/acceptor
intensity images were used to correlate the results visually.
Flourescence time lapse imaging
Cells were grown on chambered cover glass (Lab-Tek
TM, Nunc,
Rochester, NY), to which, the indicated drugs reconstituted in
DMEM containing 5% FBS was added. For imaging, cells were
stained as described and imaged in a live cell incubation chamber
(Tokai Hit, Japan) that maintains optimum CO2, temperature and
humidity. Imaging was carried out under a 206Plan Apo 1 NA
objective under an inverted fluorescence microscope (Nikon
Eclipse, TE2000-E) equipped with a CARV II confocal imager
(Becton Dickinson) either in confocal or non confocal mode and
an automated excitation and emission filter wheel. The images
were captured using EMCCD camera Andor iXON 885 using
IPLab software (BD, USA) at regular intervals for the indicated
time periods. To minimize photobleaching, the intensity of the
light was reduced to 1% by intensity iris control. For ratio imaging
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and CFP emission was collected using 483622 nm band pass
filter. FRET channel was collected using 542627 nm band pass
filter.
Detection of FRET by flow cytometry
CFP/YFP ratio analysis by FACS was performed in a
FACSAria II (BD Biosciences) equipped with a 407 nm laser.
Briefly, cells seeded in 12-well plates were treated with drugs. At
the end of drug treatment, cell were trypsinized, washed twice with
PBS and passed through a 40 mm sieve (BD Biosciences) before
FACS analysis. To measure ECFP, cells were excited with the
407 nm laser and fluorescence was collected in the ECFP channel
with the standard 450640 nm filter, while the EYFP FRET signal
(for measurement of Venus) was measured with a 530630 nm
filter. For each sample, we evaluated a minimum of 20,000 cells
that fell within the background adjusted gate. In the scatter plot of
ECFP Vs EYFP, the events that were detected within the gate
drawn corresponding to increased ECFP and reduced EYFP were
taken as cells with loss of FRET.
Live cell staining
Hoechst 33342 staining. Following drug treatment, treated
and untreated cells were stained with 2 mg/ml Hoechst 33342
(Molecular Probes #H1399) in phenol-red free DMEM
containing 5% FBS by incubating at 37uC for 10 minutes.
Unbound dye was washed off by gently washing twice with PBS.
Hoechst 33342 intensity was imaged for detecting pycnotic nuclei.
Cells were counterstained with TMRM (Molecular Probes #T-
668) or MitoSOX
TM Red (Molecular Probes #M36008) after
Hoechst staining. TMRM staining: For TMRM staining, cells
were incubated with 150 nM TMRM at 37uC for 10 mins
following which, unbound dye was washed off. Stained cells were
replenished with 5 nM TMRM containing 5% phenol red-free
DMEM for imaging MMP loss. MitoSOX Red staining:
MitoSOX
TM Red mitochondrial superoxide indicator is a
fluorigenic dye for highly selective detection of superoxide in the
mitochondria of live cells. For staining, cells were loaded with 5%
DMEM containing 5 mM MitoSOX
TM Red and incubated for
10 minutes at 37uC, protected from light. Cells were washed thrice
gently with PBS to remove excess unbound dye and replaced with
fresh 5% phenol-red free DMEM.
Highthroughput screening: acquisition, segmentation
and analysis
Image acquisition. For HTS imaging, cells were seeded in 96
well glass bottom plates (Greiner Bio-One) at desired density. After an
overnight culture, medium was removed and replenished with
phenol-red free DMEM containing 5% FBS with the compounds to
be tested at the appropriate working concentrations. Plates were
imaged under BD Pathway
TM 435 Bioimager (Becton Dickinson
Biosciences, USA). The filter combination for CFP/YFP FRET was
designed as described for microscopic imaging with independent
automated control of excitation, emission and dichroic filter wheels
for easy adaptation of CFP/YFP ratio image acquisition with other
parameters of choice. The excitation/dichroic mirror/emission filter
combinations used for imaging were 438624/458LP/483632,
438624/458LP/542627, 562640/593LP/624640 and 377650/
409LP/435LP for CFP, CFP-YFP FRET, TMRM/MitoSOX and
Hoechst channels respectively for multiparmater high throughput
image acquisition. Images for each well were acquired in the
respective channels using a dry 206objective with NA 0.75. Images
were captured as single montage/363/666 montages. For caspase
inhibition, cells were pretreated for 1.5 hours with the respective
caspase inhibitors Caspase inhibitor VI, Caspase 8 inhibitor I and
Caspase 9 inhibitor II (Calbiochem) for inihibiting caspase 3, 8 and 9
activities respectively, following which, cells were subjected to drug
treatment in the following manner: MCF7 SCAT3 and SCAT9 cells
with Staurosporine (250 nM) and SCAT8 cells with Anisomycin
(2 mg/ml) for 10 hours. At the end of the incubation timeperiod, cells
were subject to imaging for FRET loss positive cells.
Post acquisition segmentation and analysis. Post-
acquisition image analysis was done using BD AttoVision
TM
(Version 1.6/435, Becton Dickinson Biosciences, USA) by applying
simple polygon segmentation or polygon band segmentation for
demarcating cytoplasmic and nuclear regions separately at the
automatic threshold level and variable dilation as well as erosion
width. Optimized segmentation masks were created for each
experiment by an in-built distance-map based split algorithm for
separating touching cells with desired erosion factor based on the cell
type. Data was read out in the form of images and dot plots, with
FRET ratio loss (increased DEVDase activity) corresponding to
increased ECFP/EYFP ratio signal, TMRM intensity loss for
mitochondrial membrane potential (MMP) loss, increase in
Hoechst 33342 intensity for chromatin condensation and
MitoSOX intensity gain for mitochondrial superoxide generation.
Data export and quantitation. Following automated
segmentation and ROI identification, the data was exported to
BD FacsDiva
TM and gates were applied for the corresponding
quantitative read-outs. Gates were made in each experiment
keeping basal apoptosis parameter in untreated controls below
10%. Read out of cells with greater FRET loss and chromatin
condensation than the setthreshold was taken as events in the upper
quadrant, whereas, for MMP loss, those in the lower quadrant were
considered. For the generation of intensity maps and Z
’
factor values, data was exported to BD Image Data Explorer
TM
(Version 2.2.15, BD Biosciences, USA). In order to estimate
the ‘screenability’ of the HCS assay, Z
’ factor values were calculated
using the equation Z
’=12(3*StdDevsample+3*StdDevcontrol)/
(Meansample2Meancontrol).
SDS-PAGE and Western blotting
50 mg protein sample was resolved electrophoretically in 12%
SDS–polyacrylamide gel and electro transferred onto a Hybond
C
TM extra nitrocellulose membrane (Amersham Biosciences) by
wet transfer procedure (Bio-Rad Mini Protean11). The mem-
brane, after blocking with 5% BSA in TBST was incubated with
primary antibody overnight at 4uC. The primary antibodies used
were: rabbit anti-GFP (#2555, Cell Signaling Technology), mouse
anti-caspase 8 (#9746, Cell Signaling Technology), mouse anti-
caspase 3 (#9662, Cell Signaling Technology), caspase 9
(#551247, BD Pharmingen), Cleaved caspase 3 (#9661, Cell
Signaling Technology) and mouse anti-b actin (#A5316, Sigma) at
1:1000 dilutions. The membranes were then incubated in horse-
radish peroxidase labeled anti-rabbit or anti-mouse secondary
antibodies (Sigma) at 1:4000 dilutions for 1 hr and developed
using Enhanced Chemi Luminescence assay (Amersham
TM ECL
Plus western blotting detection kit, GE healthcare, Buckingham-
shire, UK) or DAB (Sigma).
Results
Validation of the caspase sensor transfected stable
clones for presence and functionality of caspase sensor
probe
The image-based high content screening (HCS) methodology
described here utilizes intracellular FRET-based caspase activity
High Content Ratio Imaging for Apoptosis Detection
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acceptor fluorophores. A panel of cell lines with the transfected
probes was stably generated as described in Materials and Methods
(Table S2), which were then validated for the presence of the
transfected gene product using different methods. Employing
fluorescence time lapse imaging, FRET probe cleavage, which
corresponded to an increase in cyan coloured (CFP channel) over
green colored (YFP channel) cells was taken as the read out for
caspase activation (Figure S1, Movie S1) with untreated cells not
showing any such change. Once caspase activation was thus
qualitatively confirmed by fluorescence imaging (Figure 1 C–F),
quantitation of the same in single cells was performed by confocal
microscope-aided FRET acceptor bleaching method as described
in Materials and Methods. From this, in MCF7 SCAT3, MCF7
SCAT8 and MCF7 SCAT9 cells, untreated population gave
FRET efficiencies of 23.2862.08%, 28.3766.94% and
22.1062.78% respectively, whereas the population treated for
12 hrs with Staurosporine (STA) gave reduced FRET efficiencies
of 5.3260.69%, 6.764.04% and 8.2160.40% in the respective
cell variants. Caspase inhibitors for the three caspases reversed the
FRET loss information as seen by the reduction in FRET loss
positive cells (Figure 1 G) (Supplementary Fig. S3). In order to
confirm whether SCAT probe cleavage was comparable to the
corresponding endogenous caspase activation pattern, we probed
samples of HeLa cells treated with Apicidin, Anisomycin and
Cisplatin for caspase full length protein cleavage as well as SCAT
probe cleavage. The results displayed similar activation profiles
between the two, thereby confirming the utility of the probes as a
direct read-out for the endogenous caspase activation; SCAT3 for
DEVDase, SCAT8 for IETDase and SCAT9 for LEHDase
activity (Figure 1 J). Further, using flow cytometer-based FRET
detection, we confirmed the results obtained through western
blotting (Figure 1 K). Also, a kinetics analysis of the percentage of
cells showing FRET loss upon treatment with few drugs (data of
Cisplatin shown) for SCAT3/8/9 probe cleavage was done by
flow cytometry, which showed a gradational activation pattern
over a time period of 0 to 24 hrs studied, with a surge of activation
after 8 hrs post treatment (Figure 1 L,M). This shows that the
panel of cell lines developed could also be used to study kinetics of
percentage of cells with active caspases over a period of time. Also,
in order to address the issue of transfectioninduced artifacts in the
apoptotic response, we looked for the percentage of apoptotic
nuclei in untransfected and transfected cells (Figure 1N). It is
noteworthy that cell reponse does not significantly vary in both the
cases. All these methods thus confirmed the functionality of the
probes in the stable cell lines generated both qualitatively as well as
quantitatively.
The HCS platform is adaptable for high content
apoptosis analysis
Once validation of the engineered cells were complete, a
platform for high content imaging and apoptosis analysis using
these cell lines was designed (Figure 2). A representation of the
output data is also shown (Figure 3). First, in OVCAR8 SCAT3
cells we used a random panel of drugs (in duplicates) from that
given in Supplementary information to check for the adaptability of
the method for high content screening. For this, cells were
imaged at 0, 6, 18, 36 and 48 hrs post drug treatment. Data was
analysed using polygon segmentation, where, FRET signal was
measured in the whole cell. By the segmentation applied,
neighboring cells could be clearly demarcated and apoptotic
bodies as well as spread out cells could be picked up together for
analysis. The cells imaged with 363 montage acquisition as well
as single montage image with respective segmentation masks are
represented in Figure 4A. In general for most comparative data
generation, cells were imaged with 363 montage to cover large
population of cells from each well. In the pattern of drug activity
obtained, some drugs were found to be active very early after
drug treatment, while others displayed a slow, gradational
activation (Figure 4B). Slight caspase activation could be picked
up even as early as 6 hrs post treatment, which could be neatly
followed up upto the 48 hrs time point analysed. Thus, it was
confirmed that this could be adapted as a sensitive and reliable
assay methodology for high content caspase activation profiling of
live cells.
The HCS platform is adaptable for multiparameter
apoptosis analysis
Since a high content screening platform to assay multiple
apoptosis parameters like caspase activation, MMP loss and
chromatin condensation simultaneously in live cells has not been
reported yet, we wanted to check for the adaptability of this
platform for such a multiparameter apoptosis analysis. Initially
spinning Disk confocal imaging was carried out to check the
suitability for multiparamater imaging of MMP loss together with
ratio analysis for caspase activation status in live cells. MCF7
SCAT 3 cells treated with Actinomycin D after staining with
MMP indicator TMRM were imaged using CARV confocal
imager by time lapse as described. The representative images from
multiple time points and video of merged channels are shown in
Figure S2, Movie S2. As seen from the figure and movie,
temporal information of loss of TMRM fluorescence and FRET
can be easily monitored visually. For high throughput analysis,
OVCAR8 cells stably transfected with SCAT3 was treated with 42
drugs (in duplicates) for 20 hrs. Following drug treatment, cells
were imaged for the above-mentioned parameters under the BD
pathway imager as described in Materials and Methods. We obtained,
among these, 19 positive hits displaying variable MMP loss, FRET
ratio loss and chromatin condensation response patterns depend-
ing on the mechanism of action of the drug (Figure 5). From the
results, even at 20 hrs post treatment, the drugs Cyclophospha-
mide, Mitoxantrone, Monastrol, Apigenin, 17 DMAG, Apoptosis
Activator I and Indomethacin displayed only a loss in mitochon-
drial membrane potential (MMP loss) that was not accompanied
by a correspondingly elevated caspase activation or chromatin
condensation. DNA damaging agents Cisplatin, Actinomycin D,
and Camptothecin, HDAC inhibitor Trichostatin A, kinase
inhibitors 5,6-dichloro 1,b-D ribofuranosyl benzimidazole and
Staurosporine and Lactacystine were found to induce FRET ratio
loss without a correspondingly massive MMP loss. This points
towards a Dym- independent DEVDase activity possible with
drugs that induce damage of DNA or associated machinery. On
the other hand, FRET loss, MMP loss and chromatin condensa-
tion were all found to be induced by translation inhibitors
Cycloheximide, Anisomycin as well as Novobiocin and Gossypol
at 20 hrs post treatment. Furthermore, starvation (0.5% serum in
culture medium HBSS) condition for 20 hrs induced chromatin
condensation and slight reduction in MMP, without significant
caspase activation.
Further, in order to look at the correlation between mitochon-
drial superoxide (SOX) generation and MMP loss along with
FRET loss and chromatin condensation in the same cells, we
stained separate wells with mitochondrial SOX indicator dye
MitoSOX Red and TMRM dye. Eight positive hits were selected
on the basis of robust variations (Figure 6). We found a high
correlation between MitoSOX gain and TMRM loss in all the
drugs tested, except for Gossypol, which induced considerably very
high SOX production when compared to the MMP loss. Our
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and toxic activities of Gossypol without a correspondingly massive
MMP loss could be due to the massive superoxide generation and
an alternate superoxide-mediated, MMP loss-independent apop-
tosis signaling mechanism. To highlight the multiparameter
potential of the method, chromatin condensation and FRET ratio
loss channels of the same experiment have also been shown.
Overall, the results highlight the potential of the platform to
identify non-classical death signaling induced by chemical entities
in a high throughput manner with high content multiparameter
analysis.
Adaptability for assaying multiparameter kinetics
For assaying DEVDase activity as a function of time, HeLa
SCAT3 cells were treated with a panel of 42 drugs (in duplicates)
and imaged at specified time intervals over a period of 0 to
72 hours post drug treatment. Both DEVDase activity and
chromatin condensation were assayed in these cells over time.
Heat maps depicting the drug response helped identify 24 positive
hits that showed gradational DEVDase activity over time
(Figure 7). Out of these, 12 hits showed very gradual increase
in both DEVDase activity and chromatin condensation kinetics,
which is depicted as ‘Response group A’, while 7 showed very high
activity even as early as 12 hrs after drug treatment, depicted as
‘Response Group B’. A reduction in the read out by 72 hrs in
some of the populations is due to the loss of cells in the wells
because of excessive cell death. A representative image set and
quantitative information of the two response groups have been
shown. Our results show that a similar kinetics response pattern is
observed among compounds with a common mechanism of
action. Hsp90 inhibitors 17AAG, 17DMAG and Radicicol
showed a slow, but consistent effect in inducing DEVDase activity
and chromatin condensation. Similarly, HDAC inhibitors SBHA,
Apicidin and Trichostatin A as well as ER stress inducers
Tunicamycin and TG also showed a similar effect. On the other
hand, DNA Topoisomerase inhibitors Camptothecin and Novo-
biocin that directly inhibit the DNA caused massive chromatin
condensation at 12 hr itself, but with only a slower effect on the
DEVDase activity over time. Translation inhibitors Cyclohexi-
mide and Anisomycin, flavonoids Apigenin and Gingerol, Bcl-2
antagonist HA-14-1 as well as CK1 & CK2 inhibitor 5,6-dicloro
1,b-D ribofuranosyl benzimidazole had equal effect on inducing
rapid DEVDase activity and chromatin condensation as early as
12 hr after drug treatment. Multiparameter death signaling
signatures obtained with drugs of differing mechanisms of action
points to the fact that apoptosis centered algorithms can be
developed for profiling large chemical libraries for unknown
functions.
Adaptability for comparing differential drug sensitivity
among cell lines
Response to a particular drug varies from one cell type to
another. We wanted to check the adaptability of our method to
compare such differences among cell lines. For this, we
generated SCAT3 transfected U251 and HeLa stable cell lines,
which were treated with a panel of 37 drugs (in duplicates) and
the DEVDase activity was imaged and analysed at 48 hrs post
treatment. The differential response pattern showed that
glioblastoma U251 cells were responsive to a greater range of
compounds under the study, when compared to cervical
adenocarcinoma HeLa cells (Figure 8). U251 cells were most
sensitive to Trichostatin A, Sulindac, Actinomycin D, TRAIL,
SBHA and Apicidin followed by Radicicol, Mevinolin, Gossypol,
Camptothecin, MG132, TG and Licochalcone. HeLa cells
showed most sensitivity towards Actinomycin D and Licochal-
cone, moderate sensitivity towards Radicicol, Gossypol, SBHA
and Apicidin, followed by Sulindac and Mimosine. Taken
together, Actinomycin D was found to be inducing DEVDase
activity both the cell lines under study, although with differing
strengths.
Our result reinforces the idea of differential sensitivity of
different cell lines to a set of drugs and thereby projects itself as a
useful tool in the initial screening for identifying the best set of
apoptosis inducing compounds before delving into the mechanism
of action in a particular cell line.
Comparison of IETDase, LEHDase and DEVDase activity
against MMP loss
Next, we wanted to make a simultaneous comparative study of
IETDase and LEHDase activity together with DEVDase activity
and its correlation with Dym. For this, we generated stable clones
of HeLa cells transfected with SCAT3, SCAT8 and SCAT9,
which gave a direct read out of DEVDase, IETDase and
LEHDase activity respectively. At 12 hrs after drug treatment, as
expected, we found considerable variability in the induction of
probe cleavage by different drugs (Figure 9). We found
Cycloheximide, Anisomycin, 5,6-dicloro1,b-D ribofuranosyl
benzimidazole (RBZ), Gossypol and Camptothecin to be most
active in inducing IETDase activity and HA-14-1, 4-aminohy-
droxyflavone and Apoptosis Activator I in inducing LEHDase
activity. Most of the drugs induced DEVDase activity, the most
prominent of those being Apigenin, Mevinolin, RBZ, Cyclohex-
imide, Actinomycin D, Camptothecin, Apoptosis Activator I and
Anisomycin. When comparing the probe cleavage with MMP
loss, we found a good correlation of LEHDase activity with MMP
loss when compared to IETDase activity that was largely not
correlated with MMP loss. The DEVDase activity was always
Figure 1. Validation of caspase activity sensor probes. (A) Schematic representation of the FRET probes with corresponding caspase
substrate-specific linkers. (B) The schematic representation of the default FRET between ECFP and Venus in untreated cells and its loss upon linker
cleavage is shown. (C) Merged image of ECFP and FRET channels of untreated MCF7 SCAT3 cells (D) Merged image of ECFP and FRET channels of
MCF7 SCAT 3 cells after treatment with staurosporine (500 nM, 12 hrs). (E) Ratio pseudo-image of the same cells untreated and (F) staurosporine
treated cells. Arrows depict a representative cell showing FRET loss. (G) Histogram showing reversal of percentage of high FRET loss positive cells
upon treatment with the corresponding caspase inhibitor in MCF7 SCAT3, SCAT8 and SCATcells. The cells were subjected to drug treatment in the
following manner: MCF7 SCAT3 and SCAT9 cells with Staurosporine (250 nM) and SCAT8 cells with Anisomycin (2 mg/ml) for 10 hours.selected based
on the maximal activity observed. Images shown in Supplementary figure S3 (H) Confocal-based FRET acceptor bleaching in MCF7 cells showing pre-
bleach and post-bleach images of untreated and treated (STA 500 nM, 12 hrs) (I) FRET efficiency calculated from confocal acceptor bleaching
experiments of cells expressing indicated probes with and without STA treatment. (J) Immunoblot of the drug treated HeLa SCAT3, SCAT8 and SCAT9
cells and the corresponding cleavage of endogenous caspases as well as SCAT, probed with anti-GFP (K) Percentage of cells with ECFP-EYFP FRET loss
analysed for the indicated probe-expressing HeLa cells analysed by FACS after treatment for indicated time points. (L) Flow cytometry scatter plot of
% cells with high ECFP- EYFP FRET ratio loss of HeLa SCAT3, SCAT8 and SCAT9 cells after 0 h, 4 h, 8 h 12 h and 24 h of Cisplatin (50 mg/ml) treatment:
and graphical (M) representation. (N) Untransfected MCF7 cells and its SCAT3/SCAT8/SCAT9 transfected counterparts tested for % apoptotic nuclei
after Cisplatin (50 mg/ml, 10 hrs) treatment.
doi:10.1371/journal.pone.0020114.g001
High Content Ratio Imaging for Apoptosis Detection
PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e20114accompanied with MMP loss, except in the case of Mevinolin
where, FRET ratio loss happened without much reduction in the
MMP loss. Thus, this screening platform integrates signals of
multiple parameters associated with apoptosis signaling from
individual cells so as to generate a final picture of the response of
the population as a whole.
Drug resistant cells execute caspase 9 independent cell
death
One of the greatest features of the multi-well plate imaging tool
used here is the option of revisit imaging of the same well for
longer periods of time, thereby enabling precise fate analysis of the
surviving fraction. We identified cell colonies that survived drug
Figure 2. Schematic overview of the high-content imaging methodology. The method utilizes 96 well plate ratio imaging as the primary
readout of caspase activity in cells stably expressing caspase cleavable FRET probe as described earlier. The pathway Bio imager was configured with
ECFP and EYFP FRET filter as described in the materials and methods. The cells were seeded on 96 well glass bottom plates at the desired density and
image acquisition was done in an automated on-the-fly ratio mode with desired montage option at regular time intervals. Post acquisition analysis
was done using Attovision software after automated segmentation into nuclear and cytoplasmic channels, followed by conversion of qualitative data
to quantitative data. The quantitative ROI information is converted in to list mode that can be analysed in any flow cytometer based software. The
cumulative information helps in the identification of positive hits.
doi:10.1371/journal.pone.0020114.g002
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PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e20114treatment in the first round of treatment with 3 classes of drugs viz
HDAC inhibitors (TriA, SBHA), translation inhibitors (Aniso,
CHX) and microtubule inhibitors (Podo, Colchi) (Figure 10 i).
When these surviving cells were subjected to a second round of
treatment with the same drugs, we found that they took a longer
time to respond, and showed a divergent caspase 9 activation
response. At 24 hrs post drug treatment, cells that survived after
treatment with microtubule inhibitors remained more resistant to
a second phase of drug treatment; compared to HDAC inhibitors
and translation inhibitors. For comparing death reponse, we
scored for the percentage of cells that lost normal growing
adherent morphology (rounded cells), treating these as dead cells
(Figure 10 ii). The population that survived the first round of
drug treatment showed a significant reduction in the percentage of
dead cells at 24 hrs when compared to the same period of drug
treatment of the parental population. The escaped population also
exhibited a lesser level of caspase 9 activation in the rounded cells.
This is clearly evidenced in the shown FRET ratio heat images by
the absence of high FRET loss positive (orange) rounded cells in
the escaped drug treated population, when correlated with the
representative qualitative heat map.
Discussion
One of the earliest reports on the potential of GFP-FRET
based caspase activation detection for anticancer drug screening
in live cells came out in 2000 [26] with several improvisations of
this method in the coming years such as advancements in
fluorescence signal strength, stability and sensitivity [29–31].
Since the readout is from these assays are from well based
integrated signal after meticulous background correction, they
have limitation in multi-parameter pathway defining or deriving
the single cell information. The HTS screening platform
described here has several advantages starting from improved
stability of probes used to adaptability for high content
multiparameter apoptosis analysis in live cell mode. In compar-
Figure 3. A representative output data with multiparmater analysis. A representative output data from OVCAR8 SCAT3 cells showing FRET
loss with increase in donor blue fluorescence upon drug treatment in the CFP/YFP merge channels (B,I) with the corresponding FRET ratio pseudo-
color channel (A, H) TMRM (D,K) and Hoechst fluorescence channels (C,J) (untreated: A–E, Camptothecin (10 mM, 12 hrs) treated H–L). Segmentaion
mask (polygon band) showing spatial demarcation between nucleus and cytoplasm for both untreated (F&G) and camptothecin (10 mM, 12 hrs)
treated (M&N) are also shown. The corresponding post-analysis quantitation carried out by FACS Diva software after indicated treatment is shown
(O–R). Percentage of desired apoptosis parameter are shown in the corresponding gated areas FRET loss (O), hoechst intensity (P) and TMRM
intensity (Q). Dot plot showing biparameter analysis of TMRM intensity Vs FRET loss (R).
doi:10.1371/journal.pone.0020114.g003
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conventional anticancer drug screening, this platform gives a
more physiologically relevant mechanistic picture of the drug
activity in the initial screening stage itself. The possibility of on-
the-fly acquisition-cum-segmentation-cum-analysis also highlights
its superiority over other drug screening platforms. Also, the
methodology is simple, in comparison to the enormity of
information that is obtained. Further, as tumor etiology varies
Figure 4. The HCS platform is adaptable for high content apoptosis analysis. OVCAR8 cells treated with a random panel of drugs in
duplicates were imaged at the time points: 0 hr, 6 hr, 18 hr, 36 hr, 48 hr post drug treatment. Simple polygon segmentation was applied (A) and
segmentation parameters were optimized to pick out intact cells as well as apoptotic bodies. Montages of 161 and 363 are shown to highlight the
possibility of choosing different montage types based on the type of experiment or to increase the number of cells for analysis. Bar chart showing
time kinetics of FRET ratio loss upon drug treatment at the indicated time points (B). The same area and same cells are represented over a period of
time indicating potential for readout of kinetics.
doi:10.1371/journal.pone.0020114.g004
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PLoS ONE | www.plosone.org 10 May 2011 | Volume 6 | Issue 5 | e20114from one carcinoma type to another, stable generation of these
sensor probes in a large panel of cells will enable for
comprehensive cell-to-cell comparative study in a kinetic mode.
Z factor, which defines the screenability of any particular
highthrouput assay, was found to be above 0.7 in all our
experiments and for the entire cell lines used, thus demonstrating
the usability in large compound library screening.
The development of novel molecularly targeted cancer
therapeutics remains slow and expensive with many late-stage
failures. This is because most of the frequently used anti-cancer
Figure 5. High content multiparameter analysis: FRET ratio loss, TMRM intensity and chromatin condensation. OVCAR8 cells stably
transfected with SCAT3 was treated with 42 drugs (in duplicates) for 20 hrs. Following drug treatment, cells were imaged for FRET ratio loss, TMRM
loss and chromatin condensation under the BD pathway imager as described in Materials and Methods. Polygon band segmentation was applied and
the 19 positive hits obtained displaying variable MMP loss, FRET ratio loss and chromatin condensation response patterns are shown. (A Images of
FRET ratio loss, TMRM and chromatin condensation are shown, (B) with the corresponding scatter plot representation obtained through data export
and analysis in BD FACSDiva software.
doi:10.1371/journal.pone.0020114.g005
Figure 6. High content multiparameter analysis: FRET ratio loss, TMRM intensity, chromatin condensation and MitoSOX
production. For simultaneous imaging and correlation between mitochondrial superoxide (SOX) generation and MMP loss along with FRET ratio
loss together with chromatin condensation in the same cells, OVCAR8 SCAT3 cells were stained in separate wells with mitochondrial SOX indicator
dye MitoSOX Red and TMRM dye. 8 positive hits were selected on the basis of robust variations (A) Images of FRET ratio loss, mitochondrial
superoxide and chromatin condensation from the same well and the (C) corresponding TMRM pattern from a different well (B) Biparametric dot plot
showing comparison of MitoSOX and FRET ratio loss. Encircled area shows the response patterns with each drug.
doi:10.1371/journal.pone.0020114.g006
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PLoS ONE | www.plosone.org 12 May 2011 | Volume 6 | Issue 5 | e20114therapies were discovered based on their anti-proliferative activity
or cytotoxicity as end point detection in cell-based assays, with no
pre-existing knowledge of their targets of action. This kind of a
unified approach in drug discovery fails in revealing potential
anticancer agents with varied modes of action as a result of which,
none of the currently used drugs selectively and directly target the
molecular lesions responsible for malignant transformation. Most
importantly, considering the enormous evidence linking cancer
and apoptosis, it appears that screens of apoptosis rather than anti-
proliferative activity are far more superior screens for anticancer
drug development. Accordingly, the present study set forth to
develop a rational strategy based on live cell apoptosis detection as
a useful tool to obtain a better mechanistic understanding of newer
anticancer agents. The major highlight of this study is that the
conclusions drawn on the response of the population are actually
derived by recording the response of each single cell. Therefore
the results bear very low noise. Interestingly, soon after drug
addition, some wells showed a high DEVDase read out due to the
intrinsic fluorescence interference of the drug itself, which
remained equally intense upto the assay end point. To the
advantage of this methodology, such a display makes the
technique suitable for early detection of any spurious signal,
thereby preventing the possibility of wrongly interpreting an
otherwise negative hit.
Before designing the HTS methodology, we validated the
functionality of the probes in the stably generated cell lines by live
cell imaging based fluorescence microscopy, FRET acceptor
bleaching by confocal microscopy, immunoblotting for FRET
Figure 7. Adaptability for assaying multiparameter kinetics. For assaying DEVDase activity as a function of time, HeLa SCAT3 cells were
treated with a panel of 42 drugs (in duplicates) and imaged at the time points: 1 hr, 12 hr, 22 hr, 36 hr, 72 hr post drug treatment for both DEVDase
activity and chromatin condensation. (A) Heat map of kinetics of FRET ratio loss at the indicated time points. Quantitation of the same was used to
plot bar charts for (B) DEVDase activity (C) and chromatin condensation at the indicated time points, showing 2 response groups with 24 positive
hits. Mevinolin and Indomethacin, representative drugs of the two response groups are shown (D, E) with upper panel showing CFP/YFP merge,
FRET ratio loss and chromatin condensation images and lower panels showing dot plot representations of FRET ratio loss and chromatin
condensation at the indicated time points. Details of well positions of drugs used are given in Supplementary Figure S4. Additional details of drug
concentration, known mechanism of action have been given in Supplementary Table 2.
doi:10.1371/journal.pone.0020114.g007
Figure 8. Adaptability for comparing differential drug sensitivity among cell lines. To check for adaptability of the method to compare for
differences among cell lines, stably generated U251 SCAT3 and HeLa SCAT3 cells were treated with a panel of 37 drugs (in duplicates) and the
DEVDase activity was imaged and analysed at 48 hrs post treatment. 29 hits were identified that showed significant variation from untreated
controls. (A) U251 SCAT3 and (B) HeLa SCAT3 cells are shown.
doi:10.1371/journal.pone.0020114.g008
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flow cytometry. We found the cleavage pattern of the transfected
probe to be corresponding to that of the activation of the
endogenous caspases, thereby showing their suitability for use in
further experiments to assay caspase activity. In addition, since
there was no significant variation in the percentage of apoptotic
nuclei in the untransfected and transfected cell lines, the possibility
of transfection-induced artifacts can be ruled out. In fact, we
carried out mild selection and flow sorting, thereby being less
invasive in enriching the transgene-containing cells, specifically to
address this concern. With a simple methodology and using stably
generated caspase sensor cell lines, we then developed a high
content screening platform that could be adaptable for live cell
multiparameter imaging, time kinetics study and cell line-to-cell
line comparison of various apoptosis parameters such a mito-
chondrial membrane potential (MMP) loss, chromatin condensa-
tion, mitochondrial superoxide generation together with caspase
activation. From our studies, we demonstrate the potential of this
high content screening platform in giving integrated information
of the varied effects of different drugs based on their mechanism of
action. We propose that multiparameter death signaling signatures
obtained with drugs of differing mechanisms of actions could be
used for developing apoptosis centered algorithms for profiling
large chemical libraries for unknown functions.
Figure 9. Comparison of IETDase, LEVDase and DEVDase activity against MMP loss. Hela cells stably expressing SCAT3, SCAT8 and SCAT9,
after 12 hrs treatment with a panel of drugs were imaged for IETDase, LEHDase and IETDase activity (A) Qualitative data was quantified and is
represented as bar chart. SCAT3, SCAT8 and SCAT9 FRET ratio loss are represented side-by-side for comparison (B) Corresponding biparameteric dot
plots showing comparison of IETDase, LEHDase and IETDase activity against MMP loss are shown. The drugs shown here are positive hits obtained
from a larger panel of drugs used.
doi:10.1371/journal.pone.0020114.g009
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generation, we found a high correlation between the two in all the
drugs tested, except Gossypol, which induced considerably very
high SOX production when compared to Dym. Gossypol, a
polyphenolic aldehyde is known to induce Bax/Bak independent
cytochrome c release by mediating a conformational change in
Bcl2 [32]. In addition, Gossypol has been shown to be mediating
free radical toxicity in isolated rat islet cells [33], oxygen radical
formation in rat liver microsomes and human sperms [34] as well
as ROS mediated growth inhibition in prostate cancer cells. Our
multiparameter HTS results indicate that the growth inhibitory
and toxic activities of Gossypol without a correspondingly massive
MMP loss could be due to the massive superoxide generation and
an alternate superoxide-mediated, MMP loss-independent apop-
tosis signaling mechanism.
Our observation of certain cells that maintain MMP loss
without caspase activation or chromatin condensation at a late
stage post-drug treatment suggest that the actual ‘point-of-no-
return’ of apoptosis is a much more complex event that could
probably be ultimately dependent on the mode of action of the
death inducer. Also, through this method, compounds that
activate caspases independent of the mitochondria-dependent
pathway could be detected.
So far, simultaneous detection of apoptosis and mitochondrial
superoxide production in live cells worked best with flow
cytometry and confocal microscopy [35], which suffer from the
disadvantage of either being cumbersome or time-consuming for
large scale compound screening. Here we report the first ever
comparison of quantitative data on mitochondrial superoxide
generation and caspase activity derived from live single cell
imaging and thus project the possibility of this methodology in
large scale compound screening and generation of multiparameter
cell signaling information with a single experiment.
In our multiparameter kinetics analysis, we got two ‘response
groups’ of drugs, with one showing gradual activation and the
other showing sudden activation. Also, we have compared the
IETDase, LEVDase and DEVDase activity against MMP loss in
HeLa cells, thereby showing the advantage of this screening
platform in giving a comprehensive picture of initator and
effector caspase activation in the same cell line. A favourable
improvement of this could be the use of a three chromophore
FRET based system using for e.g, CFP-YFP-mRFP for the
simultaneous detection of multiple caspases or other enzymes
within the same cell [36]. Another major advantage of this
method is the possibility of following up of the respective wells for
subsequent fate, whereby we have identified rare escape of cells
from caspase activation with certain antitumor agents. In a
unique experiment, we could also show emergence of drug-
escaped colonies and their subsequent response to a second cycle
of drugs. Employing such a technique, we show that cells that
escaped after treatment with cell cycle inhibitors stay more
resistant to subsequent re-treatment compared to HDAC
inhibitors, translation inhibitors. Most of the stable cell lines
described here were clonally expanded and their stable
expression have been followed up for more than 200 passages
without any significant loss of function and expression. Therefore,
they can form a ready-to-use method for HTS-based drug
screening applications. However, if this needs to be adopted for
other cell lines, stably integrated colonies with optimum FRET
efficiency need to be generated as described here. As an extension
to our results, we also suggest a future possibility of stable
generation of sensor probes in the entire NCI cell line panel with
simultaneous multiparameter signaling analysis will help to define
the pathway signatures of each drug and may augment selection
of best hits from the early screening effort. This is also expected to
augment the identification of unusual non classical apoptosis
inducers from large libraries in less time.
Supporting Information
Movie S1 Visualization of FRET loss over time. MCF7
SCAT3 cells grown on chambered cover glass was treated with
Camptothecin and imaged every 10 minutes after drug addition in
controlled temperature and humidity conditions. Imaging was
done using Nikon inverted fluorescent microscope under 206NA
1.0 objective and Andor 885 camera. The frame rate is 30 frames
per second.
(AVI)
Movie S2 Simultaneous visualization of TMRM loss and
caspase activation. MCF7 SCAT3 cells stained with MMP
indicator dye TMRM was treated with Actinomycin D and
imaged every 10 minutes after drug addition. Imaging conditions
are same as mentioned in Supplementary Movie S1. The frame
rate is 30 frames per second.
(AVI)
Figure S1 Visualization of FRET loss over time by
widefield ratio imaging. Images of Camptothecin treated
MCF7 SCAT3 cells at 1 hr, 10 hr and 18 hr after drug addition
taken from live cell imaging. Imaging conditions are same as
mentioned in Supplementary Movie S1. Arrows indicate some
representative cells that show FRET loss at the indicated time
points.
(TIF)
Figure S2 Simultaneous visualization of TMRM loss
and caspase activation. Confocal images of Actinomycin D
treated MCF7 SCAT3 cells counterstained with TMRM for
visualizing MMP loss at 4 hr, 16 hr and 20 hr after drug addition.
Imaging conditions are same as mentioned in Supplementary
Movie S1. Arrows indicate some representative cells that show
FRET loss at the indicated time points.
(TIF)
Figure S3 Validation of FRET sensor probe: Caspase
inhibition reverses FRET loss pattern. Panels A–D, E–H
Figure 10. Drug resistant cell execute caspase 9 independent cell death. (i) HeLa SCAT9 cells were treated with a large panel of drugs and
subject to revisit imaging of the surviving cells. Panels A to F show parental cells just prior to drug treatment. G to L represent cell response 24 hrs
after the first round of treatment with the indicated drugs. Here, white and red solid arrows indicate representative live adherent (FRET loss negative)
and dead rounded (high FRET loss positive) cells respectively. M to R show colonies out of cells that survived the first round of drug treatment. S to X
and Y to AD show the response of the same area of the surviving population after 24 hrs and 48 hrs respectively upon second treatment of the
escaped population with the same drugs. In panels S to X, white and yellow solid arrows indicate representative live adherent (FRET loss negative)
and dead rounded (high FRET loss negative) cells respectively. Heat map shows the representative qualitative low to high FRET loss index (ii)
Histogram showing percentage of HeLa SCAT9 cells with detached rounded morphology (dead cells) of parental population (light grey solid bars)
and escaped population (dark grey solid bars) at 24 hrs post drug treatment with the 6 indicated drugs belonging to 3 classes of mechanism of
action.
doi:10.1371/journal.pone.0020114.g010
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Inhibitor alone treated cell populations of MCF7 SCAT3, SCAT8
and SCAT 9 cells respectively. Cells were subjected to drug
treatment in the following manner: MCF7 SCAT3 and SCAT9
cells with Staurosporine (250 nM) and SCAT8 cells with
Anisomycin (2 mg/ml) for 10 hours.
(TIF)
Figure S4 Well positions of drugs (Supplementary informa-
tion to Figure 7) Well positions in 96 well format of the drugs used
for kinetics study of caspase activation and chromatin condensa-
tion in HeLa SCAT3 cells. Detailed information on Drug
concentrations used and the mechanism of action of drugs is
given in Supplementary Table 2.
(TIF)
Table S1 List of cell lines used in the study.
(DOC)
Table S2 Details of drugs used in the study.
(DOC)
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